Leyte-Vidal, A., Outhwaite, I., Miller, K., Gebauer, E., Alvarez, A., Leavitt, C., Ahmadieh, N., Farrell, B., Kwan, I., Branford, S., Maqsood, M., Yeung, D., Hughes, T., Oehler, V., Rea, D., Landgraf, R., Bahar, I., Seeliger, M., Shah, N. (2025). Numerous clinically-detected asciminib-resistant BCR::ABL1 mutations disrupt allostery and confer cross-resistance to the novel clinically-active allosteric TKI tgrx-678. Blood. https://doi.org/10.1182/blood-2025-1516